T2 Biosystems Stock Alpha and Beta Analysis
| TTOO Stock | USD 0.01 0.01 50.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as T2 Biosystems. It also helps investors analyze the systematic and unsystematic risks associated with investing in T2 Biosystems over a specified time horizon. Remember, high T2 Biosystems' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to T2 Biosystems' market risk premium analysis include:
Beta 12.32 | Alpha 21.17 | Risk 139.66 | Sharpe Ratio 0.16 | Expected Return 21.68 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
TTOO |
T2 Biosystems Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. T2 Biosystems market risk premium is the additional return an investor will receive from holding T2 Biosystems long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in T2 Biosystems. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate T2 Biosystems' performance over market.| α | 21.17 | β | 12.32 |
T2 Biosystems expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of T2 Biosystems' Buy-and-hold return. Our buy-and-hold chart shows how T2 Biosystems performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.T2 Biosystems Market Price Analysis
Market price analysis indicators help investors to evaluate how T2 Biosystems pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading T2 Biosystems shares will generate the highest return on investment. By understating and applying T2 Biosystems pink sheet market price indicators, traders can identify T2 Biosystems position entry and exit signals to maximize returns.
T2 Biosystems Return and Market Media
The median price of T2 Biosystems for the period between Sat, Oct 4, 2025 and Fri, Jan 2, 2026 is 0.012 with a coefficient of variation of 60.8. The daily time series for the period is distributed with a sample standard deviation of 0.01, arithmetic mean of 0.01, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About T2 Biosystems Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TTOO or other pink sheets. Alpha measures the amount that position in T2 Biosystems has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
T2 Biosystems Upcoming Company Events
As portrayed in its financial statements, the presentation of T2 Biosystems' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, T2 Biosystems' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of T2 Biosystems' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of T2 Biosystems. Please utilize our Beneish M Score to check the likelihood of T2 Biosystems' management manipulating its earnings.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with T2 Biosystems
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in TTOO Pink Sheet
T2 Biosystems financial ratios help investors to determine whether TTOO Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TTOO with respect to the benefits of owning T2 Biosystems security.